A Health Economic Model to Assess the Long-Term Effects and Cost-Effectiveness of Orlistat in Obese Type 2 Diabetic Patients

Diabetes Care - United States
doi 10.2337/diacare.25.2.303
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Orlistat and L-Carnitine Compared to Orlistat Alone on Insulin Resistance in Obese Diabetic Patients

Endocrine Journal
EndocrinologyMetabolismDiabetes
2010English

Development of an Economic Model to Assess the Cost-Effectiveness of Proton Beam Therapy in Patients With Hepatocellular Carcinoma in Japan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Assessment of Pharmacological Responses to an Anti-Diabetic Drug in a New Obese Type 2 Diabetic Rat Model

Medicinski Arhiv
Medicine
2017English

Pdb64 - Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients With Type 2 Diabetes

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Serum Levels of Chemerin and Omentin 1 in Obese Type 2 Diabetic Patients.

International Journal of Advanced Research
2016English

Pdb74 - Ideglira Versus Iglarlixi for Patients With Inadequately Controlled Type 2 Diabetes on Basal Insulin: A Long-Term Cost-Effectiveness Analysis in the Czech Republic

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Immediate and Long-Term Effects of a Very-Low-Calorie Diet on Diabetes Remission and Glycemic Control in Obese Thai Patients With Type 2 Diabetes Mellitus

Food Science and Nutrition
Food Science
2019English

Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients With Type 2 Diabetes Receiving Basal–Bolus Therapy

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

The Use of Key Indicators to Assess Latin America's Long-Term Economic Performance

CEPAL Review
DevelopmentEconomicsEconometricsFinance
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy